---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-032979"
form_type: "8-K"
ticker: "CGTX"
cik: "0001455365"
company_name: "COGNITION THERAPEUTICS INC"
filed_at: "2024-03-11T23:59:59+00:00"
generated_at: "2026-06-04T23:45:17.608106+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cognition Therapeutics reports preliminary FY2023 net loss of $25.6M; cash at $29.9M

## Summary
- Preliminary net loss for FY2023 expected to be approximately $25.6 million.
- Cash and cash equivalents as of Dec 31, 2023: $29.9 million.
- Results are unaudited and subject to revision upon completion of audit.
- No revenue reported; company is a clinical-stage biotech.

## SEC filing metadata
- accession: 0001104659-24-032979
- form_type: 8-K
- ticker: CGTX
- cik: 0001455365
- company_name: COGNITION THERAPEUTICS INC
- filed_at: 2024-03-11T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1455365/000110465924032979/0001104659-24-032979-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1455365/000110465924032979/tm248362d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-032979
- JSON: https://secwatch.observer/filing/0001104659-24-032979.json
- Plain text: https://secwatch.observer/filing/0001104659-24-032979.txt

## Key facts
- Earnings Releases
  COGNITION THERAPEUTICS INC reported the year ended December 31, 2023 results: net income approximately $25.6 million.
  - Period: the year ended December 31, 2023
  - Net income: approximately $25.6 million
  - Result: preliminary results
  source text: Preliminary unaudited consolidated operating results for the year ended December 31, 2023 and certain preliminary financial condition information as of December 31, 2023 are as follows: · Net loss for the year ended December 31, 2023 is expected to be approximately $25.6 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1455365/000110465924032979/0001104659-24-032979-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.